Cover Image

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction

Background: We aim to investigate the guideline adherence of β-blocker (BB) initiating dose in Chinese hospitalized patients with heart failure with reduced ejection fraction (HFrEF) and whether the adherence affected the in-hospital outcomes.Methods: This was a retrospective study of patients hospi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yiling Zhou (Author), Yuping Zeng (Author), Si Wang (Author), Nan Li (Author), Miye Wang (Author), Ify R. Mordi (Author), Yan Ren (Author), Youlian Zhou (Author), Ye Zhu (Author), Haoming Tian (Author), Xin Sun (Author), Xiaoping Chen (Author), Zhenmei An (Author), Chim C. Lang (Author), Sheyu Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
by: Chang Liu, et al.
Published: (2021)

Cost-Effectiveness Analysis of Ultrasound Screening for Thyroid Cancer in Asymptomatic Adults
by: Nan Yang, et al.
Published: (2021)

Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
by: Jixue Tan, et al.
Published: (2021)

A Comparison of Functional Features in Chinese and US Mobile Apps for Diabetes Self-Management: A Systematic Search in App Stores and Content Analysis
by: Wu, Yuan, et al.
Published: (2019)

Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy
by: Wu, Yuan, et al.
Published: (2018)

Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy
by: Wu, Yuan, et al.
Published: (2017)

Exercise for sarcopenia in older people: A systematic review and network meta‐analysis
by: Yanjiao Shen, et al.
Published: (2023)

Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction
by: Dima Nasrallah, et al.
Published: (2024)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023)

Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant myocarditis
by: Tingting Xie, et al.
Published: (2022)

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
by: Xiao Wang, et al.
Published: (2024)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021)

Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk
by: Jun-Feng Li, et al.
Published: (2023)

Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction
by: Qiang Wang, et al.
Published: (2022)

The Role of Epicardial Adipose Tissue-Derived Proteins in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation: A Bioinformatics Analysis
by: Huang K, et al.
Published: (2024)

Study of correlation between right ventricular ejection fraction with left ventricular ejection fraction in patients of chronic heart failure with diabetes, using two-dimensional echocardiography
by: Vandan Shah, et al.
Published: (2024)

Plasma digoxin levels and ejection fraction in pediatric heart failure
by: Nafrialdi Nafrialdi, et al.
Published: (2016)

New to paradigm for the treatment of heart failure with reduced ejection fraction?
by: Delfín Rodríguez Leyva
Published: (2015)

Pediatric heart failure with preserved ejection fraction, a review
by: Sophie Quennelle, et al.
Published: (2023)

Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure
by: Wang K, et al.
Published: (2017)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022)

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
by: He Lu, et al.
Published: (2023)

Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease
by: Zhaowei Zhang MD, et al.
Published: (2024)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
by: James P. Teuber, et al.
Published: (2022)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021)

Pediatric heart failure classification based on left ventricular ejection fraction
by: Shan Huang, et al.
Published: (2023)

Role of ARNI upgraded in treatment of heart failure with reduced ejection fraction
by: Swetha Amaresh Biradar
Published: (2021)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018)

Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
by: Ali Çoner, et al.
Published: (2021)

Left ventricular thrombus formation in a patient with normal ejection fraction
by: Nihan Kahya Eren, et al.
Published: (2013)

How to treat cardiac dyssynchrony in heart failure with reduced ejection fraction
by: Bogdan Stefan, et al.
Published: (2024)

Understanding cardiac systolic performance beyond left ventricular ejection fraction
by: Elena-Laura Antohi, et al.
Published: (2020)

Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole
by: Caroline Silveira Martinez, et al.
Published: (2024)

Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
by: Yujian Fan, et al.
Published: (2023)

Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction
by: Natasha Fillmore, et al.
Published: (2018)

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: M. V. Kurkina, et al.
Published: (2017)

Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol
by: Roland Gal, et al.
Published: (2020)

DIASTOLIC LEFT VENTRICULAR DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ELDERLY
by: CALENICI Oleg, et al.
Published: (2022)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
by: Artem Ovchinnikov, et al.
Published: (2022)

Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function
by: Thomas A. Mavrakanas, et al.
Published: (2019)